Respiratory Syndrome Coronavirus 2
📧 Sign up to get email alerts when something new happens for Respiratory Syndrome Coronavirus 2.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure [Phase 2, Phase 3]
Phase 2/3 clinical trial update for INO-4800 in adults at high risk for SARS-CoV-2 exposure; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine [Phase 3]
A Phase 3 trial update for the SARS-CoV-2 rS vaccine sponsored by Cogna Technology Solutions LLC has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: COVID-19 and Anti-CD14 Treatment Trial [Phase 2]
Phase 2 trial of anti-CD14 treatment for COVID-19/SARS-CoV-2 has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 [Phase 3]
Phase 3 trial evaluating inhaled interferon-β for COVID-19 has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection [Phase 2, Phase 3]
Clinical trial update for early treatment in vulnerable individuals with non-severe SARS-CoV-2 infection spanning Phase 2 and Phase 3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis [Phase 3]
Phase 3 trial evaluating isavuconazole to prevent COVID-19-associated pulmonary aspergillosis; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS [Phase 1, Phase 2]
Clinical trial update on using umbilical cord-derived mesenchymal stromal cells for SARS-CoV-2-related ARDS, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection [Phase 2, Phase 3]
Phase 2/3 clinical trial update for NA-831 (atazanavir and dexamethasone) in COVID-19 infection; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Treatment of SARS Caused by COVID-19 With Ruxolitinib [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ruxolitinib for treatment of COVID-19 related SARS-CoV-2 infection has been completed.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Convalescent Plasma in the Treatment of COVID 19 [Phase 2]
Phase 2 clinical trial updating convalescent plasma for treatment of COVID-19, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Tocilizumab in Coronavirus-19 Positive Patients [Phase 3]
Phase 3 clinical trial update for tocilizumab in COVID-19 patients; current status is unknown.